Anti-septic effects of pellitorine in HMGB1-induced inflammatory responses in vitro and in vivo

Inflammation

Volumn 37, Issue 2, 2014, Pages 338-348

  Ku, Sae Kwang ^a   Lee, In Chul ^b   Kim, Jeong Ah ^c   Bae, Jong Sup ^c  

^a Daegu Haany University   (South Korea)

^b Seowon University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

barrier dysfunction; HMGB1; pellitorine; sepsis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PELLITORINE; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASARUM; ASARUM SIEBOLDII; CECAL LIGATION AND PUNCTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LIGATION; MALE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; POLYUNSATURATED ALKAMIDES; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896328782     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9745-5     Document Type: Article

References (44)

1. Goodwin, G.H.; C. Sanders, and E.W. Johns. 1973. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. European Journal of Biochemistry 38: 14-19.
2. Bustin, M.; D.A. Lehn, and D. Landsman. 1990. Structural features of the HMG chromosomal proteins and their genes. Biochimica et Biophysica Acta 1049: 231-243.
3. Bae, J.S. 2012. Role of high mobility group box 1 in inflammatory disease: Focus on sepsis. Archives of Pharmacal Research 35: 1511-1523.
4. Nogueira-Machado, J.A.; C.M. Volpe, C.A. Veloso, and M.M. Chaves. 2011. HMGB1, TLR and RAGE: A functional tripod that leads to diabetic inflammation. Expert Opinion on Therapeutic Targets 15: 1023-1035.
5. Russell, J.A.; and K.R. Walley. 2013. Update in sepsis 2012. American Journal of Respiratory and Critical Care Medicine 187: 1303-1307.
6. Andersson, U.; and K.J. Tracey. 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annual Review of Immunology 29: 139-162.
7. Han, A.R.; H.J. Kim, M. Shin, M. Hong, Y.S. Kim, and H. Bae. 2008. Constituents of Asarum sieboldii with inhibitory activity on lipopolysaccharide (LPS)-induced NO production in BV-2 microglial cells. Chemistry and Biodiversity 5: 346-351.
8. Kim, S.J.; C. Gao Zhang, and J. Taek Lim. 2003. Mechanism of anti-nociceptive effects of Asarum sieboldii Miq. radix: Potential role of bradykinin, histamine and opioid receptor-mediated pathways. Journal of Ethnopharmacology 88: 5-9.
9. Oh, J.; I.H. Hwang, D.C. Kim, et al. 2010. Anti-listerial compounds from Asari Radix. Archives of Pharmacal Research 33: 1339-1345.
10. Quang, T.H.; N.T. Ngan, C.V. Minh, et al. 2012. Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii. Bioorganic & Medicinal Chemistry Letters 22: 2527-2533.
11. Stohr, J.R.; P.G. Xiao, and R. Bauer. 2001. Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro. Journal of Ethnopharmacology 75: 133-139.
12. Park, I.K. 2012. Insecticidal activity of isobutylamides derived from Piper nigrum against adult of two mosquito species, Culex pipiens pallens and Aedes aegypti. Natural Product Research 26: 2129-2131.
13. Reddy, S.V.; P.V. Srinivas, B. Praveen, et al. 2004. Antibacterial constituents from the berries of Piper nigrum. Phytomedicine 11: 697-700.
14. Ee, G.C.L.; C.M. Lim, M. Rahmani, K. Shaari, and C.F.J. Bong. 2010. Pellitorine, a potential anti-cancer lead compound against HL60 and MCT-7 cell lines and microbial transformation of piperine from Piper nigrum. Molecules 15: 2398-2404.
15. Lee, W.; S.K. Ku, T.H. Kim, and J.S. Bae. 2013. Emodin-6-O-beta-d- glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo. Food and Chemical Toxicology 52: 97-104.
16. Ley, J.P.; J.M. Hilmer, B. Weber, G. Krammer, I.L. Gatfield, and H.J. Bertram. 2004. Stereoselective enzymatic synthesis of cis-pellitorine, a taste active alkamide naturally occurring in tarragon. European Journal of Organic Chemistry: 5135-5140.
17. Ku, S.K.; E.J. Yang, K.S. Song, and J.S. Bae. 2013. Rosmarinic acid down-regulates endothelial protein C receptor shedding in vitro and in vivo. Food and Chemical Toxicology 59C: 311-315.
18. Lee, W.; T.H. Kim, S.K. Ku, et al. 2012. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models. Toxicology and Applied Pharmacology 262: 91-98.
19. Yang, E.J.; W. Lee, S.K. Ku, K.S. Song, and J.S. Bae. 2012. Anti-inflammatory activities of oleanolic acid on HMGB1 activated HUVECs. Food and Chemical Toxicology 50: 1288-1294.
20. Kim, T.H.; S.K. Ku, I.C. Lee, and J.S. Bae. 2012. Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Reports 45: 200-205.
21. Che, W.; N. Lerner-Marmarosh, Q. Huang, et al. 2002. Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circulation Research 90: 1222-1230.
22. Bae, J.W.; and J.S. Bae. 2011. Barrier protective effects of lycopene in human endothelial cells. Inflammation Research 60: 751-758.
23. Akeson, A.L.; and C.W. Woods. 1993. A fluorometric assay for the quantitation of cell adherence to endothelial cells. Journal of Immunological Methods 163: 181-185.
24. Kim, I.; S.O. Moon, S.H. Kim, H.J. Kim, Y.S. Koh, and G.Y. Koh. 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. Journal of Biological Chemistry 276: 7614-7620.
25. El Gazzar, M. 2007. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflammation Research 56: 162-167.
26. Mullins, G.E.; J. Sunden-Cullberg, A.S. Johansson, et al. 2004. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scandinavian Journal of Immunology 60: 566-573.
27. Bae, J.S.; and A.R. Rezaie. 2011. Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118: 3952-3959.
28. Chen, G.; J. Li, M. Ochani, et al. 2004. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. Journal of Leukocyte Biology 76: 994-1001.
29. Buras, J.A.; B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: Setting the stage. Nature Reviews Drug Discovery 4: 854-865.
30. Sama, A.E.; J. D'Amore, M.F. Ward, G. Chen, and H. Wang. 2004. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. Academic Emergency Medicine 11: 867-873.
31. Wolfson, R.K.; E.T. Chiang, and J.G. Garcia. 2011. HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption. Microvascular Research 81: 189-197.
32. Qin, Y.H.; S.M. Dai, G.S. Tang, et al. 2009. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. Journal of Immunology 183: 6244-6250.
33. Sun, C.; C. Liang, Y. Ren, et al. 2009. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Research in Cardiology 104: 42-49.
34. Treutiger, C.J.; G.E. Mullins, A.S. Johansson, et al. 2003. High mobility group 1 B-box mediates activation of human endothelium. Journal of Internal Medicine 254: 375-385.
35. Yang, E.J.; S.K. Ku, W. Lee, et al. 2013. Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo. Journal of Cellular Physiology 228: 975-982.
36. Lin, W.N.; S.F. Luo, C.B. Wu, C.C. Lin, and C.M. Yang. 2008. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: Involvement of Src/EGFR/PI3-K/Akt pathway. Toxicology and Applied Pharmacology 228: 256-268.
37. Ruiz-Torres, M.P.; G. Perez-Rivero, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and M.L. Diez-Marques. 2006. The leukocyte-endothelial cell interactions are modulated by extracellular matrix proteins. Cellular Physiology and Biochemistry 17: 221-232.
38. Aziz, M.; A. Jacob, W.L. Yang, A. Matsuda, and P. Wang. 2013. Current trends in inflammatory and immunomodulatory mediators in sepsis. Journal of Leukocyte Biology 93: 329-342.
39. Rose, B.A.; T. Force, and Y. Wang. 2010. Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiological Reviews 90: 1507-1546.
40. Angelillo-Scherrer, A. 2012. Leukocyte-derived microparticles in vascular homeostasis. Circulation Research 110: 356-369.
41. Hayden, M.S.; and S. Ghosh. 2012. NF-kappaB, the first quarter-century: Remarkable progress and outstanding questions. Genes and Development 26: 203-234.
42. Grall, F.; X. Gu, L. Tan, et al. 2003. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis and Rheumatism 48: 1249-1260.
43. Branen, L.; L. Hovgaard, M. Nitulescu, E. Bengtsson, J. Nilsson, and S. Jovinge. 2004. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 2137-2142.
44. Takeda, R.; E. Suzuki, H. Satonaka, et al. 2005. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 111: 1398-1406.